Protease inhibitors modify induction of endogenous type C oncornavirus.
D000818:Animals; D000976:Antipain / Q000494:pharmacology*; D002472:Cell Transformation, Viral / Q000187:drug effects; D002478:Cells, Cultured; D007065:Idoxuridine / Q000037:antagonists & inhibitors / Q000378:metabolism; D007976:Leupeptins / Q000494:pharmacology*; D051379:Mice; D009842:Oligopeptides / Q000494:pharmacology*; D011480:Protease Inhibitors / Q000494:pharmacology*; D012190:Retroviridae / Q000254:growth & development*; D014779:Virus Replication / Q000187:drug effects*
D007976:Leupeptins; D009842:Oligopeptides; D011480:Protease Inhibitors; D000976:Antipain; D007065:Idoxuridine